As New Zealanders (and Australians) know, melanoma is problem in our harsh sunlight. This looks a promising start on a personalised mRNA-based melanoma vaccine. – The 42% reduction is compared to standard treatment, the monoclonal antibody Keytruda. – FWIW, Moderna has a base in Melbourne.
Similar posts
3 posts close in meaning, closest first
Quick summary of the Moderna melanoma “vaccine“ It’s not really a preventative / prophylactic vaccine as we usually understand the term, it’s a therapeutic administered to patients who have had surgically removed skin cancer
“The study found that the patients who received the vaccine after surgery to remove their tumors were 42 percent less likely to have a recurrence of the cancer or to die within two years as those who did not receive the vaccine.” www.nytimes.com/2026/10/22/w...
'The latest trial results provided more information, specifically about the timing for a patient’s survival. After six months, the combination of mRNA and Merck’s cancer-killing drug Keytruda reduced the risk of tumour recurrence or death by 58 per cent, the companies said.'
